Annual Revenue
N/A
March 1, 2024
Summary
- GRCE annual revenue is not available.
Performance
GRCE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
N/A
September 1, 2024
Summary
- GRCE quarterly revenue is not available.
Performance
GRCE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 1, 2024
Summary
- GRCE TTM revenue is not available.
Performance
GRCE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
GRCE Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
GRCE Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Grace Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | $196.00 K(-56.5%) | $115.00 K(+42.0%) | $196.00 K(+142.0%) |
| Dec 2020 | - | $81.00 K(-727.9%) | $81.00 K(>+9900.0%) |
| Feb 2016 | - | -$12.90 K(-439.5%) | $300.00(-100.4%) |
| Nov 2015 | - | $3800.00(-28.3%) | -$67.50 K(+46.4%) |
| Aug 2015 | - | $5300.00(+29.3%) | -$46.10 K(+3.6%) |
| May 2015 | - | $4100.00(-105.1%) | -$44.50 K(-1535.5%) |
| Feb 2015 | - | -$80.70 K(-420.2%) | $3100.00(-98.8%) |
| Nov 2014 | - | $25.20 K(+265.2%) | $250.60 K(-0.6%) |
| Aug 2014 | - | $6900.00(-86.7%) | $252.10 K(-49.3%) |
| May 2014 | - | $51.70 K(-69.0%) | $497.70 K(+10.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2014 | $450.20 K(-36.4%) | $166.80 K(+524.7%) | $452.20 K(+44.5%) |
| Nov 2013 | - | $26.70 K(-89.4%) | $313.00 K(-56.1%) |
| Aug 2013 | - | $252.50 K(+3972.6%) | $713.50 K(+1.9%) |
| May 2013 | - | $6200.00(-77.5%) | $700.00 K(-1.0%) |
| Feb 2013 | $707.40 K(+6637.1%) | $27.60 K(-93.5%) | $707.10 K(+22.4%) |
| Nov 2012 | - | $427.20 K(+78.7%) | $577.70 K(+283.9%) |
| Aug 2012 | - | $239.00 K(+1697.0%) | $150.50 K(-270.1%) |
| May 2012 | - | $13.30 K(-113.1%) | -$88.50 K(+423.7%) |
| Feb 2012 | $10.50 K(-63.8%) | -$101.80 K(-219.9%) | -$16.90 K(-114.8%) |
| May 2011 | - | $84.90 K(+192.8%) | $113.90 K(+292.8%) |
| Feb 2011 | $29.00 K | $29.00 K | $29.00 K |
FAQ
- What is the all time high annual revenue for Grace Therapeutics?
- What is the all time high quarterly revenue for Grace Therapeutics?
- What is the all time high TTM revenue for Grace Therapeutics?
What is the all time high annual revenue for Grace Therapeutics?
Grace Therapeutics all-time high annual revenue is $707.40 K
What is the all time high quarterly revenue for Grace Therapeutics?
Grace Therapeutics all-time high quarterly revenue is $427.20 K
What is the all time high TTM revenue for Grace Therapeutics?
Grace Therapeutics all-time high TTM revenue is $713.50 K